EVENTIDE ASSET MANAGEMENT, LLC
Q1 2023 13F-HR Holdings
Net value change ($000)
+379,179
(7.5%)
New positions
17
Sold out positions
14
Turnover %
5.8%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2022
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| PANW | 72,907 | 73.8% |
| Shockwave Medical, Inc. | 44,283 | 542.5% |
| DOCS | 37,998 | 28.8% |
| EXAS | 34,185 | 37.0% |
| GLBE | 32,382 | 56.2% |
| LAD | 28,730 | NEW |
| SRPT | 25,811 | NEW |
| ORLY | 25,670 | 16144.7% |
| Seagen Inc. | 25,489 | 81.8% |
| ODFL | 25,013 | 19.8% |
Top Reduces (Value $000, Stocks/ETFs)
| GTM | -96,542 | -100.0% |
| IMVT | -44,005 | -67.1% |
| Prometheus Biosciences, Inc. | -41,716 | -36.7% |
| Karuna Therapeutics, Inc. | -40,382 | -39.5% |
| Horizon Therapeutics Public Ltd Co | -26,007 | -22.9% |
| BCYC | -25,272 | -100.0% |
| XMTR | -24,330 | -35.9% |
| DLO | -21,061 | -22.6% |
| AES | -17,464 | -100.0% |
| CCI | -17,009 | -35.1% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|